Applied Digital Reports Fiscal Second Quarter 2026 Results DALLAS, Jan. 07, 2026 (GLOBE NEWSWIRE) --...
Quarter
Once upon a time, the quarter zip lived a very predictable life. It showed up to corporate offsites, survived aggressively...
Recapitalization reduced net debt to $14 million as of October 31; achieved key milestones to deliver potential 2026 revenue target...
FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent Efficacy...
CASI Pharmaceuticals (NASDAQ:CASI) reported third quarter 2025 results for the period ended...
PAPZIMEOS (zopapogene imadenovec-drba) received full approval by the FDA in August PAPZIMEOS launched with a broad label in the US...
